RESUMO
Flow cytometry is a powerful tool for analysis of hematologic malignancies, that provides rapid, quantitative, and multiparametric analysis of heterogeneous cell populations, but requires standardization because of complexities in panel design and interpretation. Here, we compared the Plasma Cell Screening Tube (PCST) kit (Cytognos, Spain) in conjunction with EuroFlow antibody panels for standardization of flow cytometry to a conventional method for diagnosis of plasma cell dyscrasias. Thirty-nine bone marrow samples and one peripheral blood sample from 40 patients were tested. Thirty-three patients were diagnosed with multiple myeloma (MM), and seven were in a reactive state. In PCST implementation, eight antibodies were used for staining, including anti-CD45-Pacific Blue, anti-CD19-PECy7, anti-CD138-OC515, anti-CD38-FITC, anti-CD56-PE, anti-β2-microglobulin-PerCPCy5.5, anti-kappa-APC, and anti-lambda-APC-C750. Plasma cells were initially identified using CD38 and CD138; thereafter, CD38+, CD138+ gated cells were analyzed for CD56, CD19, CD45, cytoplasmic kappa, cytoplasmic lambda, and β2-microglobulin. Conventional flow cytometry was performed with six monoclonal antibodies, including anti-CD56-FITC, anti-kappa-FITC, anti-CD19-PE, anti-lambda-PE, anti-CD138-PECy5, and anti-CD45-PECy7 (Beckman Coulter, USA). Monoclonal plasma cells with cytoplasmic light-chain restriction were detected in 30 of 33 (90.9%) MM cases by conventional methods, and 32 of 33 (97.0%) MM cases with the PCST method. No differences were noted between PCST and the conventional method in immunophenotyping and plasma cell percentages (P=0.323). Among plasma cells, levels (%) were significantly higher by the PCST approach than those in the conventional method (97.6% vs 95.8%, P=0.010). PCST exhibited better performance for plasma cell dyscrasias diagnosis, and could improve laboratory efficiency and quality.
RESUMO
Flow cytometry is a powerful tool for analysis of hematologic malignancies, that provides rapid, quantitative, and multiparametric analysis of heterogeneous cell populations, but requires standardization because of complexities in panel design and interpretation. Here, we compared the Plasma Cell Screening Tube (PCST) kit (Cytognos, Spain) in conjunction with EuroFlow antibody panels for standardization of flow cytometry to a conventional method for diagnosis of plasma cell dyscrasias. Thirty-nine bone marrow samples and one peripheral blood sample from 40 patients were tested. Thirty-three patients were diagnosed with multiple myeloma (MM), and seven were in a reactive state. In PCST implementation, eight antibodies were used for staining, including anti-CD45-Pacific Blue, anti-CD19-PECy7, anti-CD138-OC515, anti-CD38-FITC, anti-CD56-PE, anti-β2-microglobulin-PerCPCy5.5, anti-kappa-APC, and anti-lambda-APC-C750. Plasma cells were initially identified using CD38 and CD138; thereafter, CD38+, CD138+ gated cells were analyzed for CD56, CD19, CD45, cytoplasmic kappa, cytoplasmic lambda, and β2-microglobulin. Conventional flow cytometry was performed with six monoclonal antibodies, including anti-CD56-FITC, anti-kappa-FITC, anti-CD19-PE, anti-lambda-PE, anti-CD138-PECy5, and anti-CD45-PECy7 (Beckman Coulter, USA). Monoclonal plasma cells with cytoplasmic light-chain restriction were detected in 30 of 33 (90.9%) MM cases by conventional methods, and 32 of 33 (97.0%) MM cases with the PCST method. No differences were noted between PCST and the conventional method in immunophenotyping and plasma cell percentages (P=0.323). Among plasma cells, levels (%) were significantly higher by the PCST approach than those in the conventional method (97.6% vs 95.8%, P=0.010). PCST exhibited better performance for plasma cell dyscrasias diagnosis, and could improve laboratory efficiency and quality.
RESUMO
BACKGROUND: Flow cytometry analysis of paroxysmal nocturnal hemoglobinuria (PNH) is significantly affected by the methodology used. The lack of data on the effect of age and refrigeration on PNH clone stability motivated us to study these aspects using flow cytometry. METHODS: Peripheral blood was collected from six patients, of which two presented with PNH. All samples were tested immediately and stored at room temperature (RT, 20–25℃) and at 4℃ for re-analysis at 24, 48, 72 hr and 7 days. Anti-CD59-fluorescein isothiocyanate (Beckman Coulter, USA) and anti-CD235a-phycoerythrin (PE; Beckman Coulter) were used to stain red blood cells (RBCs). Fluorescein-labeled proaerolysin (Cedarlane, Canada), anti-CD15-PE (Beckman Coulter), anti-CD24-PE-cyanin 5 (Beckman Coulter), and anti-CD45-PE-cyanin 7 (Beckman Coulter) were used to stain granulocytes. Flow cytometry was performed using a FC500 flow cytometer (Beckman Coulter). The effects of time and temperature were analyzed using generalized estimating equations. RESULTS: No significant differences in the gated percentage of RBCs and PNH clone size of RBCs were observed between the RT and 4℃ groups up to 7 days of testing. The percentage of gated neutrophils decreased with specimen age (P<0.001) and a better correlation with baseline was obtained at 4℃ than at RT (P=0.014). Neutrophil PNH clones were stable until 48 hr and 72 hr at RT and 4℃, respectively, and could not be analyzed at 7 days. CONCLUSIONS: RBC analysis was successfully performed up to 7 days. For neutrophils, testing within 48 hr is recommended, because the number of gated cells decreases significantly with age.
Assuntos
Humanos , Células Clonais , Eritrócitos , Citometria de Fluxo , Granulócitos , Hemoglobinúria Paroxística , Neutrófilos , RefrigeraçãoRESUMO
Lymphoplasmacytic lymphoma (LPL) is a low-grade B-cell neoplasm, composed of small B lymphocytes, plasmacytoid lymphocytes, and plasma cells, usually involving bone marrow and sometimes lymph nodes or spleen. LPL with bone marrow involvement and an IgM monoclonal gammopathy of any concentration is designated as Waldenström macroglobulinemia (WM). LPL associated with non-IgM monoclonal gammopathy or biclonal gammopathy is rarely observed. LPL diagnosis was based on clinical, morphological, and immunophenotypic findings. Recently, the test for L265P mutation of the myeloid differentiation factor 88 (MYD88) gene has been helpful in the diagnosis of LPL. Here, we reported the first case of LPL/WM with IgM-κ/IgA-λ biclonal gammopathy in Korea.
Assuntos
Linfócitos B , Medula Óssea , Diagnóstico , Imunoglobulina M , Coreia (Geográfico) , Linfonodos , Linfócitos , Linfoma , Mieloma Múltiplo , Fator 88 de Diferenciação Mieloide , Paraproteinemias , Plasmócitos , Baço , Macroglobulinemia de WaldenstromRESUMO
Two external quality assessment (EQA) trials of conventional newborn screening tests for phenylketonuria, galactosemia, congenital adrenal hyperplasia, maple syrup urine disease, homocystinuria, and congenital hypothyroidism, as well as newborn screening tests using tandem mass spectrometry, were performed in 2015. A total of 44 specimens in the form of dried blood spots were distributed to 16 laboratories and the response rate of these laboratories was 100%. The mean, standard deviation, coefficient of variation, median, and cut-offs were evaluated for each analyte in the newborn screening tests. Two EQA trials for the analyses of methylmalonic acid, vanillylmandelic acid, catecholamines, metanephrines, organic acids, and amino acids were also performed. A well-designed EQA program and continuous education would improve the performance of biochemical genetics tests.
Assuntos
Humanos , Recém-Nascido , Hiperplasia Suprarrenal Congênita , Aminoácidos , Catecolaminas , Hipotireoidismo Congênito , Educação , Galactosemias , Homocistinúria , Coreia (Geográfico) , Doença da Urina de Xarope de Bordo , Programas de Rastreamento , Ácido Metilmalônico , Biologia Molecular , Fenilcetonúrias , Espectrometria de Massas em Tandem , Ácido VanilmandélicoRESUMO
OBJECTIVE: Disinfection/sterilization of hospital devices prevents the occurrence of several infections; therefore, disinfectants are essential for public health. The purpose of this study was to evaluate the biocidal effect of a hypochlorous acid solution. METHODS: Hypochlorous acid solution, Neolox (Neo Chemical, Paju, Korea) obtained from Purester (Morinaga Engineering, Tokyo, Japan) was used. Antimicrobial activity of the solution against bacteria, yeasts, and mycobacteria at different exposure times (0.5, 1, 2, 5, 10, 15, and 30 minutes) was evaluated. RESULTS: All strains of bacteria and yeasts showed a 5-log10 reduction within 30 seconds of exposure to the solution, and mycobacteria showed the same reduction within 2 minutes. CONCLUSION: Hypochlorous acid solution has been widely used as a disinfectant in recent years. Neolox can be used as an effective intermediate- to high-level disinfectant for hospital infection control.
Assuntos
Bactérias , Infecção Hospitalar , Desinfetantes , Ácido Hipocloroso , Saúde Pública , LevedurasRESUMO
OBJECTIVE: Disinfectants are essential for public health and environmental hygiene. The aim of this study was to investigate the in vitro antimicrobial activity of Medizyme-Plus (Soosan Co. Ltd., Seongnam, Korea) developed for cleansing prior to disinfection/ster-ilization, against bacteria and yeasts. METHODS: Clinical isolates were exposed to Medizyme-Plus (a product containing quaternary ammonium and a protease, amylase, and lipase) for various periods (0.5, 1, 2, 5, 10, 15, and 30 minutes). After exposure, the mixtures of isolates and Medizyme-Plus were inoculated into tryptic soy broths. To enumerate the surviving bacteria or yeasts, treated isolates were inoculated onto solid agar media (blood agar, MacConkey agar, and Sabouraud dextrose agar) and cultured at 35℃. RESULTS: All strains of bacteria and yeasts showed a 5-log10 reduction within 0.5 minutes of exposure to Medizyme-Plus. CONCLUSION: Medizyme-Plus can be used as a low-level disinfectant, in addition to cleanser, for hospital infection control. It will be necessary to perform disinfection/sterilization after cleansing with Medizyme-Plus.
Assuntos
Ágar , Compostos de Amônio , Amilases , Bactérias , Infecção Hospitalar , Desinfetantes , Glucose , Higiene , Técnicas In Vitro , Saúde Pública , LevedurasRESUMO
Two trials of external quality assessment (EQA) of conventional newborn screening tests for phenylketonuria, galactosaemia, congenital adrenal hyperplasia, maple syrup urine disease, homocystinuria, and congenital hypothyroidism, as well as newborn screening tests were performed using tandem mass spectrometry in 2014. A total of 39 specimens in the form of dried blood spots were distributed to 16 laboratories and the response rate of these laboratories was 100%. Screening tests for phenylketonuria and congenital hypothyroidism did not meet the accepted performance criteria in some laboratories. The mean, standard deviation, coefficient of variation, median, and cut-offs were evaluated for each analyte in the newborn screening tests. Two trials of EQA for the analyses of methylmalonic acid, vanillylmandelic acid, catecholamines, metanephrines, organic acids, and amino acids were also performed. A well-designed EQA program and continuous education would improve the performance of biochemical genetic testing.
Assuntos
Humanos , Recém-Nascido , Hiperplasia Suprarrenal Congênita , Aminoácidos , Catecolaminas , Hipotireoidismo Congênito , Educação , Homocistinúria , Coreia (Geográfico) , Doença da Urina de Xarope de Bordo , Programas de Rastreamento , Ácido Metilmalônico , Biologia Molecular , Fenilcetonúrias , Espectrometria de Massas em Tandem , Ácido VanilmandélicoRESUMO
BACKGROUND: Blood culture is a critical test for diagnosing bloodstream infections. Frequent microbial contamination during sampling and testing leads to abuse of antimicrobial agents. We evaluated methods for reducing contamination and obtaining more reliable results. METHODS: We analyzed blood cultures obtained between 2009 and 2015. We established 6 quality indicators: true positive rate, contamination rate, blood sampling volume, number of sets of blood cultures, delayed transportation rate, and percentage of samples collected from the femoral region, with reference to the CLSI guideline M47-A, 2007. Education was provided for interns and nurses responsible for blood sampling and transportation of specimens, and data were analyzed monthly. RESULTS: At baseline, the true positive rate was 12.8%, and the contamination rate was 4.0%. During the intervention period, these were decreased to 10.9% and 1.9%, respectively. The percentage of samples smaller than 5 mL decreased from 29.7% to 2.7-11.3%. The rate of one set of blood cultures being ordered was always <5%. The delayed transportation rate decreased from 35.6% to 5.5-7.7%. Finally, the percentage of samples collected from the femoral region decreased from 41.5% to 22.0-31.0%, because of which we did not attain our goal, 20.8%. CONCLUSION: The results showed improvements in contamination rate, specimen volume, specimen transportation time, and the percentage of samples collected from the femoral region. The quality management of blood cultures in 2011 was comparatively poor, which led to increased contamination rate, large number of samples containing <5 mL of blood, and increased percentage of samples collected from the femoral region. Thus, quality improvement methods can produce more reliable results of blood cultures.
Assuntos
Anti-Infecciosos , Educação , Artéria Femoral , Veia Femoral , Melhoria de Qualidade , Indicadores de Qualidade em Assistência à Saúde , Meios de TransporteRESUMO
No abstract available.
Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Sequência de Bases , Medula Óssea/patologia , Análise Mutacional de DNA , Éxons , Imunofenotipagem , Leucemia de Mastócitos/diagnóstico , Mutação , Reação em Cadeia da Polimerase , Proteínas Proto-Oncogênicas c-kit/genéticaRESUMO
BACKGROUND: Among the multitude of tests developed for the diagnosis of hepatitis C virus (HCV) infection, the enzyme immunoassay and the chemiluminescence immunoassays (CLIA) are the most commonly used. The OraQuick HCV Rapid Antibody Test is also popular because it can detect HCV antibodies from blood or saliva within 20 minutes. In this study, we compared the performances of the OraQuick HCV Rapid Antibody Test and CLIA in the diagnosis of HCV infection. METHODS: We tested 150 serum samples from Soonchunhyang University Seoul Hospital for HCV between November 2012 and January 2013 using CLIA (ADVIA Centaur) as well as the OraQuick test. The data from both tests were compared to the results of HCV real-time PCR (COBAS AmpliPrep/COBAS TaqMan HCV test kit). RESULTS: In the PCR analysis, 59 of the 150 samples (39.3%) tested positive and 91 (60.7%) tested negative for HCV RNA. All these samples also tested positive when screened by CLIA. However, only 57 of 59 samples tested positive with the OraQuick test. Among the 91 samples found to be HCV-negative in the PCR analysis, 50 tested negative in both CLIA and the OraQuick tests. However, a discrepancy was noted among the remaining 41 samples that tested HCV-negative in the PCR analysis; 21 of these samples tested positive in both CLIA and the OraQuick tests, but the remaining 20 tested positive only in CLIA. CONCLUSIONS: Although the OraQuick test showed a marginally lower sensitivity for HCV detection than CLIA, we conclude that it is still beneficial because it is rapid and can be performed using blood and saliva samples. Our findings suggest that the OraQuick test could be an important diagnostic tool for screening HCV infection.
Assuntos
Diagnóstico , Hepacivirus , Anticorpos Anti-Hepatite C , Hepatite C , Hepatite , Imunoensaio , Técnicas Imunoenzimáticas , Luminescência , Programas de Rastreamento , Reação em Cadeia da Polimerase , Reação em Cadeia da Polimerase em Tempo Real , RNA , Saliva , SeulRESUMO
3-methylcrotonyl-CoA carboxylase deficiency is an autosomal recessive disorder characterized by a defect in leucine catabolism. We report the case of an 80-day-old patient with 3-methylcrotonyl-CoA carboxylase deficiency who had elevated levels of 3-hydroxyisovalerylcarnitine (45.56 micromol/L; reference range, C (p.Gly105Arg)] at nucleotide position 313 and a mutation caused by a heterozygous A to T transversion [c.1252A>T (p.lle418Phe)] at nucleotide position 1252. Identification of these 2 novel MCCC2 gene mutations in our patient suggested that analysis of the MCCC1 and MCCC2 genes might prove useful in the diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency.
Assuntos
Humanos , Recém-Nascido , Carnitina , Éxons , Glicina , Leucina , Programas de Rastreamento , Valores de Referência , Análise de Sequência , Espectrometria de Massas em Tandem , ValeratosRESUMO
BACKGROUND: Mycobacterial infection is a problem throughout the world along with the increase of immunocompromised patients. For this reason, there have been many methods for faster and more accurate diagnosis. In this study, we evaluated several laboratory methods for mycobacterial infection. METHODS: From January to December 2009, 635 specimens were cultured with mycobacteria growth indicator tube (MGIT) and Ogawa media. Polymerase chain reaction (PCR) was performed with the AdvanSure tuberculosis (TB)/non-tuberculosis mycobacterium (NTM) real-time PCR Kit (LG Life Sciences, Seoul, Korea). The 69 samples showing positive culture results were identified with the AdvanSure Mycobacteria Genotyping Chip Kit (LG Life Science, Seoul, Korea). RESULTS: Sixty-nine (10.9%) out of 635 samples showed positive results for mycobacterial culture. Among the 635 samples, 64 were positive in MGIT, but only 42 were positive in Ogawa media. Of the 635 samples, 607 (95.6%) showed the same results between MGIT and Ogawa and the results of 579 (95.4%) were also consistent with the TB/NTM real-time PCR results. However, in the case of NTM, only one (1/24, 4.2%) was positive in PCR. In the Mycobacteria genotyping chip analysis, the most frequently identified NTM species in descending order were M. avium, M. intracellulare, M. chelonae and M. abscessus. CONCLUSION: Culturing with a combination of MGIT and Ogawa is recommended to increase the recovery rate of mycobacteria. Although PCR missed a reasonable number of NTM, it is faster and usually gives results that concur with those from the culture. The appropriate combination of diagnostic methods with clinical correlation are necessary.
Assuntos
Disciplinas das Ciências Biológicas , Meios de Cultura , Hospedeiro Imunocomprometido , Mycobacterium , Mycobacterium tuberculosis , Micobactérias não Tuberculosas , Reação em Cadeia da Polimerase , Reação em Cadeia da Polimerase em Tempo Real , TuberculoseRESUMO
BACKGROUND: When it comes to wasting blood components, it usually means wastage before transfusion due to several reasons such as improvement of the patient's condition, death of the patient, delay of blood returning, etc. Yet blood components can sometimes can be wasted after a transfusion is started and this is referred as residual blood wastage. In this study, we analyzed the rate and causes of discarded blood components that are not used and the residual blood wastage in order to help reduce the rate of blood component wastage. METHODS: From January 2009 to December 2010, the number of and the reasons for discarded blood components without use and residual blood wastage were analyzed by reviewing the laboratory information system and wastage statements at Soonchunhyang University Seoul Hospital. RESULTS: The number of blood components issued during the study period was 24,001 units. Among them, the number of units discarded without use was 162 units (0.7%) and the number of units of residual blood wastage was 115 units (0.5%). Among the reasons for the discarded blood component without use, improvement of the patient's conditions ranked as 1st with 80 units (49.5%) and death of the patient ranked as 2nd with 42 units (25.9%). The biggest reason for the residual blood wastage was transfusion-related side effects with as many as 52 units (45.2%). Other than side effects, the wastage of residue from pediatric transfusion were 48 units (41.7%), followed by delay of surgery with 5 units (4.3%) and patients' refusal with 4 units (3.5%). CONCLUSION: The wastage of residue from pediatric transfusion was the second most common cause of residual blood wastage in our hospital. According to this, we should evaluate the routine use of pediatric transfusion bags and their cost-effectiveness in our hospital.
Assuntos
Humanos , Sistemas de Informação em Laboratório Clínico , Dissulfiram , Coreia (Geográfico)RESUMO
BACKGROUND: The contribution of the private sector to the treatment of tuberculosis (TB) is getting larger, and the private sector pays more attention to individualized, intensive care than patient monitoring or education, which would improve the microbiological cure rate or at least completion of treatment. We aim in this paper to assess the impact of the improved monitoring of patient on the treatment outcome in the private tertiary healthcare center. MATERIALS AND METHODS: We compared the data of the positive sputum cultures for TB from March 1, 2003 to March 31, 2006 (37 months) with that data from July 1, 2007 to August 31, 2008 (14 months) in single private tertiary healthcare center in the Republic of Korea (ROK). In the latter period, we notified physicians of the new culture-confirmed cases via a cellular phone short-massage-service (SMS) to prevent delayed recognition of positive cultures and we gave calls to patients to encourage treatment adherence and to complete the whole schedule of medication. RESULTS: After the intervention, initiation of anti-TB medication increased from 86.3% to 94.5% (P<0.05), the interval to medication from the first culture results was shortened from 22.9 days to 5.6 days (P=0.19) and the rate of treatment complication increased from 57.4% to 68.1% (P<0.01). CONCLUSION: Our results showed a possible strategy to improve the completion of treatment in a university hospital. Health care providers in the private sector should to improve success by better notification and monitoring in addition to their existing advanced medical resources.
Assuntos
Humanos , Agendamento de Consultas , Telefone Celular , Cuidados Críticos , Pessoal de Saúde , Monitorização Fisiológica , Mycobacterium tuberculosis , Micobactérias não Tuberculosas , Setor Privado , Parcerias Público-Privadas , República da Coreia , Escarro , Atenção Terciária à Saúde , Resultado do Tratamento , TuberculoseRESUMO
BACKGROUND: The pandemic swine origin influenza A/H1N1 2009 virus (H1N1 2009) was rapidly spread out all over the world after it was first found in April, 2009. This study was made to compare the performance of nasopharyngeal swabs and nasopharyngeal aspirates for the SD Bioline rapid influenza antigen test. METHODS: From Aug to Nov, 2009 the SD Bioline rapid influenza antigen tests were conducted with the nasopharyngeal swabs and the nasopharyngeal aspirates from the 244 specimens of patients who had come to the hospital with influenza-like illness. The data from the examination were compared with the multiplex RT-PCR as a reference standard to obtain sensitivity, specificity, positive predictive value and negative predictive value. RESULTS: The sensitivity and the specificity of the SD Bioline rapid influenza antigen tests with the nasopharyngeal swabs were 75.8%, and 93.3% respectively, and the sensitivity and specificity with the nasopharyngeal aspirates were 61.3%, and 98.3% respectively. CONCLUSION: Even if the nasopharyngeal aspirates showed the lower sensitivity than the nasopharyngeal swabs, since the specificity is higher, the nasopharyngeal aspirates are more useful because we can reduce false positive rate.
Assuntos
Humanos , Influenza Humana , Pandemias , Sensibilidade e Especificidade , Suínos , VírusRESUMO
Involvement of the central nervous system is very uncommon in multiple myeloma, observed in approximately 1% of the multiple myeloma patients. We report a case of central nervous system myelomatosis with complex chromosome aberrations in a 62-yr-old female patient, who had previously been diagnosed as multiple myeloma. Fluorescent in situ hybridization revealed 13q deletion, p53 gene deletion and IGH/FGFR3 rearrangement and chromosomal study showed complex chromosome aberrations. After four cycles of chemotherapy, the patient was admitted to the hematology department with severe headache. Plasma cells were found in the cerebrospinal fluid (CSF), and CSF immunoelectrophoresis revealed abnormal precipitin arcs against anti-IgG and anti-lambda antisera. She was given systemic chemotherapy and eight courses of intrathecal chemotherapy, which cleared plasma cells in the CSF. Two months later, she was given autologous stem cell transplantation. Three months after stem cell transplantation, central nervous system myelomatosis progressed to plasma cell leukemia and two months later,the patient expired.
Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Antineoplásicos/uso terapêutico , Neoplasias do Sistema Nervoso Central/diagnóstico , Líquido Cefalorraquidiano/citologia , Deleção Cromossômica , Terapia Combinada , Progressão da Doença , Deleção de Genes , Imunoeletroforese , Hibridização in Situ Fluorescente , Leucemia Plasmocitária/diagnóstico , Mieloma Múltiplo/diagnóstico , Plasmócitos/patologia , Precipitinas/metabolismo , Receptor Tipo 3 de Fator de Crescimento de Fibroblastos/genética , Transplante de Células-Tronco , Translocação Genética , Transplante Autólogo , Proteína Supressora de Tumor p53/genéticaRESUMO
BACKGROUND: For the diagnosis of HIV infection, enzyme immunoassay (EIA) or chemiluminescence immunoassay (CLIA) is commonly used as a screening test. Although these methods have a high sensitivity and low cost, their high false positive rate can cause confusion in the patients and clinicians until a more specific test is done. OraQuick Advance Rapid HIV-1/2 Antibody Test (OraQuick) (OraSure Technologies, USA) is a rapid test that can detect HIV-1/2 antibodies in 20 minutes. It uses oral fluid, whole blood or serum sample. In this study, we evaluated the usefulness of the OraQuick as a screening and point-of-care test for HIV infection. METHODS: From Jan 2007 to Dec 2008, 45,276 samples referred to our laboratory were tested by CLIA method using the ADVIA Centaur (Bayer Healthcare LTD., USA) for HIV-1/2 antibody detection. Among them, 74 positive and 50 negative samples were tested by the Western immunoblot assay (WIB) and OraQuick test as a case-control study. Also, oral fluids from 30 HIV patients and 48 healthy persons were tested by OraQuick test. RESULTS: The sensitivity and specificity of OraQuick test (using serum samples) were 100% and 98.8% (95% confidence interval 96.9~100%), respectively. OraQuick tests (using oral fluid samples) were all positive for HIV patients but all negative for healthy persons. CONCLUSIONS: This study suggests that OraQuick can be used successfully as a rapid test for the early detection of HIV-1/2 antibody in patients visiting emergency departments and for the prevention of HIV infection in the health care providers.
Assuntos
Humanos , Anticorpos , Western Blotting , Estudos de Casos e Controles , Atenção à Saúde , Emergências , HIV , Infecções por HIV , Imunoensaio , Técnicas Imunoenzimáticas , Controle de Infecções , Luminescência , Programas de Rastreamento , Sensibilidade e EspecificidadeRESUMO
BACKGROUND: The number of people infected with human immunodeficiency virus (HIV) continues to grow globally. Because HIV infection can be transmitted not only by sexual contact but by transfusion, the performance of diagnostic tests can not be overemphasized. However, sometimes false positive results accompanied by high sensitivity of screening tests can confuse both doctors and patients. The present study determined the positive and false positive rates from a large data set. METHODS: From May 2005 to Dec 2008, HIV screening tests were performed with samples obtained from 77,562 patients by ADVIA Centaur (Bayer Health Care LLC, Tarrytown, NY, USA). Positive samples were referred to the Seoul Research Institute of Public Health and Environment for Western immunoblot (WIB) assays. Medical records were reviewed in patients with false positive screening results. RESULTS: The number of patients with a positive screening test was 117 of 77,562 (0.15%). Among these, 56 were positive with WIB (0.07%), producing a positive predictive value for the screening test of 47.9% (56/117). Diagnoses of patients with false positive results were mainly inflammatory diseases such as chronic hepatitis, renal failure, tuberculosis and sexually transmitted diseases. Also, 12 healthy persons referred for regular medical checkup produced false positive RESULTS. CONCLUSION: Positive rates of HIV tests and diagnoses relevant with false positive screening RESULTS could provide useful information to medical personnel for diagnosis and consultation of HIV infection.
Assuntos
Humanos , Academias e Institutos , Western Blotting , Atenção à Saúde , Testes Diagnósticos de Rotina , Hepatite Crônica , HIV , Infecções por HIV , Programas de Rastreamento , Prontuários Médicos , Saúde Pública , Insuficiência Renal , Infecções Sexualmente Transmissíveis , Atenção Terciária à Saúde , TuberculoseRESUMO
We report a case of Anti-Jk(a), whose reactivity was abolished in an enzyme gel test. A 56-year-old woman was admitted to our hospital because of fever, myalgia, nausea and vomiting. Anti-Jk(a) was detected by antibody screening and an identification test using a LISS/Coombs gel card (DiaMed AG, Cressier sur Morat, Switzwerland). Its reactivity was so weak (trace ~ 1+) that an Enzyme gel card (DiaMed AG) was added to enhance the reactivity. Unexpectedly, all reactions with the enzyme-treated cells showed negative results. The patient's RBC phenotype was Jk(a-b+). The abdominal CT revealed a 6x7.5 cm sized liver abscess. Her condition improved after percutaneous catheter drainage and she was discharged on the 23rd hospital day.